While continuous glucose monitors are part of routine care for people with type 1 diabetes, there are many other people who may also benefit from real-time insight into glucose levels. Experts ...

CagriSema is a once-weekly injection of semaglutide and cagrilintide. Clinical trial results for CagriSema showed significant improvements in A1C, weight loss, and time in range, marking it as a ...

If you live with a chronic condition like diabetes, high blood pressure, or kidney disease, watching your salt intake is essential. While salt is necessary to sustain healthy functioning of the human ...

People with diabetes who are also a part of the LGBTQ community face unique challenges when it comes to healthcare, dealing with stigma and body image issues. Shawn Laib describes his personal ...

Key takeaways: Finerenone (brand name Kerendia) is an oral medication approved for people with chronic kidney disease and type 2 diabetes. New research shows that finerenone also reduces the risk of ...

In the world of diabetes management, one size does not fit all. Doing Diabetes Your Way is an ongoing video series that offers accessible, relatable content that encourages individuals to manage ...

A recent study found that SGLT-2 inhibitors, which assist the kidneys in removing sugar from the body through urine, may provide protection against dementia and Parkinson’s disease. Researchers from ...

While not completely shocked by his diagnosis with type 2 diabetes 17 years ago, broadcaster and former NFL player Mike Golic described the experience as a “slap of reality.” “I was in a profession ...

Researchers are studying an endoscopic intestinal (ReCET) therapy that treats the lining of the upper small intestine to see if it improves blood sugar management in individuals with type 2 diabetes.

Key takeaways: The mylife CamAPS FX hybrid closed-loop system has been shown to significantly improve blood sugar management and quality of life for people with type 1 diabetes of all ages. In very ...

Clinical Trials Identifier: NCT06269107 Trial Name: A Research Study to See How Well New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Levels ...

You have probably heard of time in range (TIR), but time in tight range (TITR) has slowly become popular among some diabetes experts. Whereas guidelines generally define time in range as a range of ...